Table 2 Summary of main clinical features and genetic findings in patients with P/LP or high-level candidate variants

From: Elucidation of the phenotypic spectrum and genetic landscape in primary and secondary microcephaly

Patients with P/LP findings in established disease genes

No.

Patient ID

Agea

Microcephaly subgroup

Main clinical feature

Cerebral MRI finding

Genetic finding

Disorder

Function/pathway

1

59571

10.9

PM

Moderate global DD, moderate–severe ID, muscular hypotonia, myopia, short stature, scoliosis

Abnormal gyrus, corpus callosum dysgenesis, everted hippocampi

CDK5RAP2: c.[4546G>T];[3928G>T], p.[(Glu1516*)];[(Glu1310*)], AR (CH)

MCPH3 (MIM 604804)

Centrosome, spindle and microtubule organization

2

73869

8.8

PM

Mild motor DD, moderate speech delay, moderate ID, mild feeding difficulties, cryptorchidism

Dysmorphic corpus callosum with absence of the splenium, hypoplasia of frontal horns of lateral ventricles

CDK5RAP2: c.[558_559del];[4441C>T], p.[(Glu186Aspfs*32)];[(Arg1481*)], AR (CH)

MCPH3 (MIM 604804)

Centrosome, spindle and microtubule organization

3

74812

Aborted at 23 GW

PM

Autopsy: 2-lobed right lung and accessory spleen

Autopsy: Absence of corpus callosum

PLK4: c.[1111C>T];[881T>G], p.[(Arg371*)];[(Ile294Ser)], AR (CH)

PLK4-related disorder (MIM 616171)

Centriole duplication

4

77804

0.8

PM

Moderate global DD, movement disorder

Simplified cortical gyri and dysgenesis of corpus callosum, larger cerebellum and brain stem relative to the supratentorial region

PLK4: c.[212C>T];[760_761insAC], p.[(Ser71Phe)];[(Leu254Tyrfs*2)], AR (CH)

PLK4-related disorder (MIM: 616171)

Centriole duplication

5

68978

2.1

PM

Severe global DD, seizure

Microlissencephaly with simplified cortical pattern

ASPM: c.[3796G>T];[3796G>T], p.[(Glu1266*)];[(Glu1266*)], AR (Homo)

MCPH5 (MIM 608716)

Spindle organization and orientation

6

57602

3.8

PM

Severe global DD, spastic hemiparesis, patent ductus arteriosus, vesicoureteral reflux

Simplified gyral pattern, polymicrogyria, schizencephaly

DHTKD1: c.[2185G>A];[2185G>A], p.[(Gly729Arg)];[(Gly729Arg)], AR (Homo)

2-aminoadipic 2-oxoadipic aciduria (MIM 204750)

Amino acid degradation, mitochondrial biogenesis

7

75955

3

PM

Severe global DD, decreased reflexes, severe failure to thrive, congenital cataract, hepatomegaly, micropenis

Hypomyelination, thin corpus callosum

ERCC6: c.[850G>T];[850G>T], p.[(Glu284*)];[(Glu284*)], AR (Homo)

Cockayne syndrome (MIM 133540)

DNA repair

8

75892

2

PM

Moderate to severe global DD, stereotypy, happy demeanor, truncal obesity

Mild cortical atrophy, delayed myelination

TRAPPC9: c.[3214C>T];[3214C>T], p.[(Arg1072*)];[(Arg1072*)], AR (Homo)

Autosomal recessive mental retardation 13 (MIM 613192)

Neuronal NF-kappa-B signaling

9

53792

8.3

PM

Mild global DD, mild ID, hypotonia, seizures, failure to thrive, short stature, uvula bifida, mild truncal adiposity

No abnormality in cerebral MRI

TRMT10A: c.[379C>T];[379C>T], p.[(Arg127*)];[(Arg127*)], AR (Homo)

TRMT10A-related disorder (MIM 616033)

Transcriptional regulation

10

74601

2.3

PM

Severe global DD, cerebral movement disorder, craniosynostosis, delayed visual maturation, strabismus, hyperopia, astigmatism, torticollis, atrial septal defect

Right and left plagiocephalus

1.48-Mb dup in chr2:96732519-98212850, DN

2q11.2 duplication (Riley et al.38)

KAT6A: c.3555_3556insA, p.(Ala1186Serfs*5), DN

Autosomal dominant mental retardation 32 (MIM 616268)

Transcriptional regulation

11

74444

4.5

PM

Mild global DD, muscular hypotonia, epilepsy, left central cataract, left chorioretinal coloboma, left strabismus and nystagmus

Multiple subependymal heterotopia in lateral ventricles

2-Mb del in chr1: 145940520-147922681, DN

Chromosome 1q21.1 deletion syndrome (MIM 612474)

12

74579

2.2

PM

Mild global DD, generalized hypotonia, bilateral cleft lip and cleft palate, recurrent obstipation

N/A

7.1-Mb del in chr1:172427631-179864641, DN

1q24q25 deletion (Chatron et al.39)

13

70547

7.1

PM

Moderate speech delay, moderate–severe ID, concentration deficit, EEG abnormalities, mitral valve prolapse, cyanotic episode, contractures, hip dysplasia

Enlarged subarachnoidal space

HDAC8: c.522C>A, p.(Tyr174*), DN

Cornelia de Lange syndrome 5 (MIM 300882)

Transcriptional regulation

14

32410

15.3

PM

Moderate global DD, moderate ID, bilateral hearing loss, severe progressive optic atrophy, moderate hyperopia, distal spasticity, neurogenic clubfeet, growth deficiency, steroid-resistant focal segmental glomerulosclerosis

Cerebellar hypoplasia, bilateral atrophy of optical nerves

MT-ATP6: m.9185T>C, p.(Leu220Pro), DN

MT-ATP6-related mitochondriopathy

ATP synthesis

15

70688

1.6

PM

Moderate global DD, high palate, inguinal hernia, bilateral undescended testes, sacral dimple

Abnormal signal intensity in the posterior horns of lateral ventricles, prominent Robin–Virchow area

736 Kb dup in chrX:53480222-54215972, and 660 Kb dup in chr16:29580020-30240227, XLR

Chromosomes Xp11.22 and 16p11.2 microduplication syndromes (MIM 300705 and 614671)

16

75473

2.5

PM

Severe global DD, 2 episodes of seizure

Hypoplasia of cerebellar vermis

SLC9A6: c.[615_616insT];[0], p.[(Arg206Serfs*58)];[0], XLR

Christianson syndrome (MIM 300243)

Endosome regulation

17

72526

2.8

SM

Mild–moderate global DD, brachycephaly, plagiocephaly, atactic gait, seizures, mild thrombopenia, discrete microcytic anemia

Simplified gyri, slight ventricular dilatation, slightly flattened nucleus caudatus and small pituitary gland

DYRK1A: c.665-4del, r.665_951del, p.(Ile222Aspfs*22), DN

Autosomal dominant mental retardation 7 (MIM 614104)

Neuronal proliferation, differentiation, plasticity and death

18

59484

8

SM

Severe global DD, severe ID, hypotonia, coordination problem, epilepsy, strabismus convergence, uvula bifida, growth deficiency

No abnormality in cerebral MRI

FBXO11: c.1868C>G, p.(Thr623Arg) (Gregor et al.35), DN

FBXO11-related disorder (MIM 618089)

Protein ubiquitination

19

57570

3.5

SM

Severe global DD, muscular hypotonia, growth deficiency, complex pulmonary atresia with ventricular septal defect, immune deficiency (T-cell lymphopenia), left vesicoureteral reflux

N/A

KMT2A: c.8724del, p.(Glu2908Aspfs*21), DN

Wiedemann–Steiner syndrome (MIM 605130)

Transcriptional regulation

20

72938

2.9

SM

Severe global DD, cyanotic seizures, pain insensitivity, sterotypic movements, inappropriate laughter, tonus dysregulation, cataract, dysphagia

Delayed myelination

NACC1: c.892C>T, p.(Arg298Trp), DN

NACC1-related disorder (MIM 617393)

Transcriptional regulation

21

69444

0.8

SM

DD, muscular hypotonia

No abnormality in cerebral MRI

POGZ: c.1580A>G, p.(Asp527Gly), DN

White–Sutton syndrome (MIM 616364)

Mitotic progression

22

73824

0.9

SM

Mild–moderate motor DD, mild speech delay, hypotonia, seizures, pulmonary stenosis

No abnormality in cerebral MRI

PTPN11: c.923A>G, p.(Asn308Ser), DN

Noonan syndrome (MIM 163950)

Cell growth, differentiation, mitotic cycle

23

67093

5.8

SM

Moderate global DD, muscular hypotonia, behavior abnormality, feeding difficulties, recurrent subfebrile temperature, left iris coloboma

N/A

TLK2: c.968+2T>G, p.?, DN

Autosomal dominant mental retardation 57 (MIM 618050)

DNA repair

24

74956

2.7

SM

Mild–moderate DD, muscular hypotonia, strabismus (Duane syndrome), short stature, vesicoureteral reflux due to renal tubular ectasia, joint laxity, chronic obstipation

Partial agenesis of the corpus callosum

509 Kb del in chr17:43703801-44212416, assumed DN (absent in mother)

Koolen–de Vries syndrome (MIM 610443)

25

76870

16.2

Unknown onset

Moderate–severe global DD, moderate–severe ID, epilepsy, behavior abnormalities, hearing loss, retinal dystrophy, abnormality of dental enamel, recurrent infections

N/A

KARS: c.[1772A>T];[1772A>T], p.[(Asn591Ile)];[(Asn591Ile)], AR (Homo)

Autosomal recessive deafness 89 (MIM 613916)

Protein translation

26

45969

15.3

Unknown onset

Severe global DD, severe ID, epilepsy, ataxic movement disorder, stereotypy, sleep disturbances, intermittent hyperventilation, impulsivity, scoliosis

N/A

STXBP1: c.586C>T, p.(Arg122*), DN

Early infantile epileptic encephalopathy 4 (MIM 612164)

Neurotransmitter release

27

55113

18

Unknown onset

Learning disability (no DD), ADHD, myopia, short stature

Arachnoidal cyst

TRIO: c.4615-2del, p.?, DN

Autosomal dominant mental retardation 44 (MIM 617061)

Neuronal migration

28

31773

17.8

Unknown onset

Mild motor DD, moderate speech delay, mild ID, mild muscular hypotonia, ataxia, growth deficiency

N/A

10.8-Mb del in chr7:87365891-98118059, DN

7q21.13-q22.1 deletion (Bernardini et al.40)

29

65891

12.8

Unknown onset

Moderate–severe global DD, moderate ID, axial hypotonia, distal hypertonia (passive), spastic paraparesis, hyperactivity, sleep apnea, short stature, scoliosis, hypoplasia of the pituitary gland

N/A

MECP2: c.[1138_1144del];[0], p.[(Val380Cysfs*27)];[0], XLR

Syndromic X-linked mental retardation 13 (MIM 300055)

Transcriptional regulation

30

66916

10.5

Unknown onset

Fine motor problems, moderate–severe speech delay, moderate ID, dysmetria, short stature

N/A

PQBP1: c.[459_462del];[0], p.[(Arg153Serfs*41)];[0], XLR

Renpenning syndrome (MIM 309500)

Transcriptional regulation

Patients with likely deleterious variants in high-level candidate genes

No.

Patient ID

Agea

Microcephaly subgroup

Main clinical feature

Cerebral MRI finding

Genetic finding

Protein

Function/pathway

1

81652

2.3

PM

Mild speech delay, short stature

No abnormality in cerebral MRI

SPAG5: c.[3189C>T];[1223_1224insAC], r.[3189_3198del];[=], p.[(Gly1064Glu*3)];[(Lys409Profs*19)], AR (CH)

Sperm associated antigen 5

Centriole duplication

2

68629

5.7

PM

Moderate global DD, right plagiocephaly, bilateral hyperopia, short stature, congenital primary hypothyroidism (treated), bilateral cryptorchidism

No abnormality in cerebral MRI

TEDC1 (C14orf80): c.[227-5C>G];[1111del], r.[227_267del];[=], p.[(Glu76Glyfs*11)];[(Ala371Glnfs*12)], AR (CH)

Tubulin epsilon and delta complex 1

Centriole stability

3

74091

1.8

PM

Severe global DD, spasticity, decreased hearing of both sides, short stature, low weight, vesicoureteral reflux

Atrophy of the white matter, a Dandy–Walker variant and a generalized hypertrophy of the cerebral and cerebellar structures, pontocerebellar hypoplasia

DDX1: c.[1333G>A];[1333G>A], p.[(Val445Ile)];[(Val445Ile)], AR (Homo)

Asp-Glu-Ala-Asp (DEAD) box helicase 1

RNA trafficking

4

75822

4.5

PM

Moderate–severe global DD, hirsutism

Bilateral frontal pachygyria, delayed myelination, partial agenesis of posterior corpus callosum

VPS26A: c.[404C>T];[404C>T], p.[(Thr135Ile)];[(Thr135Ile)], AR (Homo)

VPS26, retromer complex component A

Retrograde transport of proteins from endosomes to the trans-Golgi network; Wnt signaling

5

60361

4.8

PM

Mild speech delay, hyperopia, left strabismus convergens, coarctation of the aorta, hypoplastic aortic arch, ventricular septal defect, atrial septal defect, bicuspid aortic valve, and persistent left superior vena cava, and ectodermal dysplasia, brachydactyly, mainly distally shortened phalanges, nail hypoplasia, lacrimal duct obstruction, oligodontia, sensitive and dry skin

N/A

ZNRF3: c.311T>C, p.(Leu104Pro), DN

Zinc and ring finger 3

Negative regulator of the Wnt signaling pathway

  1. ADHD attention deficit–hyperactivity disorder, AR autosomal recessive, ATP adenosine triphosphate, CH compound heterozygous, DD developmental delay, DN de novo, EEG electroencephalogram, GW gestational weeks, Homo homozygous, ID intellectual disability, MCPH microcephaly primary hereditary, MRI magnetic resonance imaging, N/A not available, P/LP pathogenic or likely pathogenic, PM primary microcephaly, SM secondary microcephaly, XLR X-linked recessive.
  2. aAge at last investigation.